Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection

被引:101
作者
Wong, HT [1 ]
Cheng, SCS [1 ]
Chan, EWC [1 ]
Sheng, ZT [1 ]
Yan, WY [1 ]
Zheng, ZX [1 ]
Xie, Y [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China
关键词
DNA vaccine; foot-and-mouth disease; IgG carrier; VP1; epitopes;
D O I
10.1006/viro.2000.0607
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
VP1 is a capsid protein of foot-and-mouth disease virus (FM DV) and contains epitopes of the virus. Plasmids encoding two VPI epitopes (amino acid residues 141-160 and 200-213) and a host-self immunoglobulin molecule were constructed to produce a new type of FMD DNA vaccine. Two plasmids, namely, pCEIM and pCEIS, containing mouse immunoglobulin (IgG) or swine IgG were subjected to immunogenicity testing in mice and swine. respectively. In mice administrated pCEIM in the abdomen using a genegun, both FMDV-specific T-cell proliferation and neutralizing antibodies were detected. In swine immunized with pCEIS at the back of the ear, immune responses were achieved after the second administration. Swine showed a T-cell proliferative response with a stimulation index (SI) of up to 8.1 and a neutralizing antibody response that was able to protect suckling mice from 10(2) LD50 (lethal dose 50) FMDV challenge. To compare the immunogenicity of the DNA-based vaccine candidate, Versus the protein-based Vaccine candidates, a second group of swine was immunized with the protein F1-sclgG, which was encoded by the plasmid pCEIS. Injection with F1-sclgG elicited a T-cell proliferative response of SI < 1.7 and a neutralizing antibody response that protected suckling mice from up to 10(5) LD50 FMDV challenge. in the challenge test, three of three swine immunized with pCEIS were fully protected from FM DV challenge. (C) 2000 academic Press.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 36 条
[1]   DEVELOPMENTS IN FOOT-AND-MOUTH-DISEASE VACCINES [J].
BARTELING, SJ ;
VREESWIJK, J .
VACCINE, 1991, 9 (02) :75-88
[2]   Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine [J].
Beard, C ;
Ward, G ;
Rieder, E ;
Chinsangaram, J ;
Grubman, MJ ;
Mason, PW .
JOURNAL OF BIOTECHNOLOGY, 1999, 73 (2-3) :243-249
[3]   PROTECTION AGAINST FOOT-AND-MOUTH-DISEASE BY IMMUNIZATION WITH A CHEMICALLY SYNTHESIZED PEPTIDE PREDICTED FROM THE VIRAL NUCLEOTIDE-SEQUENCE [J].
BITTLE, JL ;
HOUGHTEN, RA ;
ALEXANDER, H ;
SHINNICK, TM ;
SUTCLIFFE, JG ;
LERNER, RA ;
ROWLANDS, DJ ;
BROWN, F .
NATURE, 1982, 298 (5869) :30-33
[4]   Towards development of T-cell vaccines [J].
Bona, CA ;
Casares, S ;
Brumeanu, TD .
IMMUNOLOGY TODAY, 1998, 19 (03) :126-133
[5]   SYNTHESIS OF FUSION PROTEINS WITH MULTIPLE COPIES OF AN ANTIGENIC DETERMINANT OF FOOT-AND-MOUTH-DISEASE VIRUS [J].
BROEKHUIJSEN, MP ;
BLOM, T ;
VANRIJN, J ;
POUWELS, PH ;
KLASEN, EA ;
FASBENDER, MJ ;
ENGERVALK, BE .
GENE, 1986, 49 (02) :189-197
[6]   NEW APPROACHES TO VACCINATION AGAINST FOOT-AND-MOUTH-DISEASE [J].
BROWN, F .
VACCINE, 1992, 10 (14) :1022-1026
[7]   DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY [J].
CAPON, DJ ;
CHAMOW, SM ;
MORDENTI, J ;
MARSTERS, SA ;
GREGORY, T ;
MITSUYA, H ;
BYRN, RA ;
LUCAS, C ;
WURM, FM ;
GROOPMAN, JE ;
BRODER, S ;
SMITH, DH .
NATURE, 1989, 337 (6207) :525-531
[8]  
CHAN EWC, IN PRESS IMMUNOGLOBU
[9]   Genetic immunization: a new era in vaccines and immune therapeutics [J].
Chattergoon, M ;
Boyer, J ;
Weiner, DB .
FASEB JOURNAL, 1997, 11 (10) :753-763
[10]   Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins [J].
Chinsangaram, J ;
Beard, C ;
Mason, PW ;
Zellner, MK ;
Ward, G ;
Grubman, MJ .
JOURNAL OF VIROLOGY, 1998, 72 (05) :4454-4457